Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
13.85
-0.25 (-1.77%)
Mar 6, 2026, 4:00 PM EST - Market closed
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 136 employees as of December 31, 2025. The number of employees increased by 13 or 10.57% compared to the previous year.
Employees
136
Change (1Y)
13
Growth (1Y)
10.57%
Revenue / Employee
n/a
Profits / Employee
-$1,064,228
Market Cap
1.53B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,379 |
| Evotec SE | 4,788 |
| Phibro Animal Health | 2,475 |
| HUTCHMED (China) | 1,780 |
| Alvotech | 1,012 |
| ANI Pharmaceuticals | 970 |
| Cronos Group | 610 |
AMLX News
- 2 days ago - Amylyx: LUCIDITY Trial Sets Stage For Q3 Inflection Point - Seeking Alpha
- 3 days ago - Amylyx Pharmaceuticals, Inc. (AMLX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 9 days ago - Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences - Business Wire
- 11 days ago - Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 - Business Wire
- 5 weeks ago - HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 2 months ago - Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S - Business Wire
- 3 months ago - Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial - Business Wire